Paterna Biosciences

From infertility to fatherhood

Overcoming male infertility: Our pioneering in vitro spermatogenesis offers new hope for starting a family.

Paterna’s mission is to improve human reproductive health.

Why this matters:

Millions Impacted: Male infertility affects countless couples worldwide, often with limited treatment options.

Scientific Breakthrough: Our in vitro Spermatogenesis (IVS) technology has the potential to redefine male fertility treatment and significantly improve in vitro fertilization (IVF) success rates.

Paradigm Shift: This isn’t just another story; it’s a major medical leap forward in improving reproductive health.

Every family deserves the chance to have children

Male infertility is a global health issue.

50% of failed in vitro fertilization cyles is due to problems with sperm.

Male infertility care lags 30 years behind in vitro fertilization-focused female treatment.

There is currently no effective, FDA-approved therapeutic for male infertility.

Why did we create Paterna Biosciences?

Paterna was started because it became almost unbearable for our founders to constantly deliver the heartbreaking news to couples that they were unable to conceive.

Determined to solve the issue of infertility, the founders began to focus on male biology (vs. female, which up until now has been the standard) and creating in vitro spermatogenesis.

Globally there are approximately 3 million IVF cycles annually. About 50% of those cycles fail and a male factor accounts for about 50% of the failed attempts. Paterna addresses this challenge.

With more funding, we will pioneer the existing science, and achieve breakthrough, world-changing results. We have already kept sperm stem cells alive and replicated longer than any other lab.

The Science.

We drive testicular stem cells to develop into healthy, optimized sperm.

By enhancing the quality of sperm, we will significantly improve the likelihood of a successful and healthy pregnancy.

Overcoming male infertility.

Our moral and ethical statement: The founders and leadership of Paterna Biosciences recognize that work with stem cells is considered controversial by some. We can restore fertility using the patient’s own stem cells.

Our position is that we can solve genetic disorders that cause male infertility and beyond. That is our sole focus. We completely reject and will not pursue this work to enable modifications of heritable social traits. We view that as immoral and will have no part in it.

Disclaimer
THE INFORMATION IN THIS DOCUMENT IS CONFIDENTIAL AND PROPRIETARY AND MUST NOT BE DISTRIBUTED TO ANY THIRD PARTY without the express written consent of Paterna Biosciences Inc. (“PATERNA”).

THIS PRESENTATION IS FOR DISCUSSION AND GENERAL INFORMATIONAL PURPOSES ONLY. IT TAKES NO ACCOUNT OF ANY SPECIFIC INVESTMENT OBJECTIVE, FINANCIAL SITUATION, OR SUITABILITY FOR THE PARTICULAR NEED OF ANY SPECIFIC PERSON WHO MAY RECEIVE THIS PRESENTATION, AND SHOULD NOT BE TAKEN AS ADVICE ON THE MERITS OF ANY INVESTMENT DECISION. THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF Paterna. any
financial projections included in the INFORMATION have been compiled by paterna and are based on assumptions supplied by paterna which have not been verified by an outside accountants. therefore, any financial projections are limited to presenting in the form of forecast information the assumptions of paterna and do not include any evaluation of the support for the assumptions underlying the forecast. the financial projections are based upon information available to paterna as of the date of the particular COMPILATION, are subject to material uncertainties, and should not be viewed as a prediction or an assurance of ACTUAL FUTURE performance; hence, no investment decision should be made based solely on any projections included in the information. any financial projections contained herein will depend upon future events, INCLUDING a wide variety of significant business, economic and competitive risks, many of which will be beyond Paterna’s control and accordingly, no assurance can be given that paterna’s assumptions will prove true, that its projected results will be achieved, or that variations between the projections and actual future results will not be material.

THIS MATERIAL DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITies DESCRIBED HEREIN IN ANY JURISDICTION TO OR FROM ANY PERSON, NOR DOES IT CONSTITUTE FINANCIAL PROMOTION, INVESTMENT ADVICE OR AN INDUCEMENT OR AN INVITATION TO PARTICIPATE IN ANY PRODUCT, OFFERING OR INVESTMENT. THIS MATERIAL IS INFORMATIONAL ONLY AND SHOULD NOT BE USED AS THE BASIS FOR ANY INVESTMENT DECISION, NOR SHOULD IT BE RELIED UPON FOR LEGAL, ACCOUNTING OR TAX ADVICE OR INVESTMENT RECOMMENDATIONS OR FOR ANY OTHER PURPOSE. NO REPRESENTATION OR WARRANTY IS MADE THAT PATERNA’s INVESTMENT PROCESSES OR INVESTMENT OBJECTIVES WILL OR ARE LIKELY TO BE ACHIEVED OR SUCCESSFUL OR THAT PATERNA’s INVESTMENT WILL MAKE ANY PROFIT OR WILL NOT SUSTAIN LOSSES. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.
NO AGREEMENT, COMMITMENT OR UNDERSTANDING EXISTS OR SHALL BE DEEMED TO EXIST BETWEEN OR AMONG PATERNA AND ANY OTHER PARTY OR PARTIES BY VIRTUE OF PATERNA FURNISHING THIS PRESENTATION OR ANY PARTY RECEIVING THIS PRESENTATION. PATERNA HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION INDICATED HEREIN AS HAVING BEEN OBTAINED OR DERIVED FROM STATEMENTS MADE OR PUBLISHED BY THIRD PARTIES. ANY SUCH STATEMENTS OR INFORMATION SHOULD NOT BE VIEWED AS INDICATING THE SUPPORT OF SUCH THIRD PARTY FOR THE VIEWS EXPRESSED HEREIN. NO WARRANTY IS MADE THAT DATA OR INFORMATION, WHETHER DERIVED OR OBTAINED FROM FILINGS MADE WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR FROM ANY THIRD PARTY, ARE ACCURATE OR COMPLETE. EXCEPT FOR THE HISTORICAL INFORMATION CONTAINED HEREIN, THE MATTERS ADDRESSED IN THIS PRESENTATION ARE FORWARD-LOOKING STATEMENTS, WHICH CAN BE IDENTIFIED by the use of forward-looking terminology such as “may,” “will,” “seek,” “should,” “Expect,” “Anticipate,” “project,” “projection,” “pro-forma,” “attempt,” “target,” “develop,” “estimate,” “intend,” “Working to,” “working toward,” “continue,” or “believe” or the negatives thereof or other VARIATIONS thereon or comparable terminology. YOU SHOULD BE AWARE THAT PROJECTIONS AND FORWARD LOOKING STATEMENTS INVOLVE CERTAIN RISKS AND ARE INHERENTLY UNCERTAIN AND ACTUAL RESULTS MAY DIFFER FROM THE PROJECTIONS AND OTHER FORWARD LOOKING STATEMENTS CONTAINED HEREIN DUE TO REASONS THAT MAY OR MAY NOT BE FORESEEABLE. NO REPRESENTATION OR WARRANTY IS MADE AS TO THE ACCURACY OR REASONABLENESS OF THE ASSUMPTIONS UNDERLYING THE PROJECTIONS AND OTHER FORWARD LOOKING STATEMENTS CONTAINED HEREIN.

ALL AMOUNTS, MARKET VALUE INFORMATION AND ESTIMATES INCLUDED IN THIS MATERIAL HAVE BEEN OBTAINED FROM OUTSIDE SOURCES THAT PATERNA BELIEVES TO BE RELIABLE OR REPRESENT THE REASONABLE JUDGMENT OF PATERNA AS OF THE DATE OF THIS MATERIAL. NO REPRESENTATION, WARRANTY OR UNDERTAKING, EXPRESS OR IMPLIED, IS GIVEN AS TO THE ACCURACY OR COMPLETENESS OF THE INFORMATION OR VIEWS CONTAINED HEREIN. PROJECTIONS, MARKET OUTLOOKS, ASSUMPTIONS OR ESTIMATES IN THIS MATERIAL ARE FORWARD-LOOKING STATEMENTS, ARE BASED UPON CERTAIN ASSUMPTIONS, AND ARE SUBJECT TO A VARIETY OF RISKS AND CHANGES, INCLUDING RISKS AND CHANGES AFFECTING INDUSTRIES GENERALLY AND THE COMPANY SPECIFICALLY.

PATERNA RESERVES THE RIGHT TO CHANGE OR MODIFY ANY OF ITS OPINIONS EXPRESSED HEREIN AT ANY TIME AS IT DEEMS APPROPRIATE. PATERNA DISCLAIMS ANY OBLIGATION TO UPDATE THE INFORMATION OR VIEWS CONTAINED HEREIN.

2749 East Parleys Way, Suite 100, Salt Lake City, UT 84109

© 2024 ALL RIGHTS RESERVED | PATERNA BIOSCIENCES
SITE CREDITS